0.57 (-%)
As of Dec 04, 2024
Source:
Vaxart, Inc is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on our Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 550-3500 |
Industry | manufacturing |
CEO | Michael J. Finney, Ph.D. |
Website | investors.vaxart.com |